# Immunic Inc. (IMUX)

Source: https://www.quantisnow.com/company/IMUX
Generated: 2026-11-06T21:52:24.729Z

- Ticker: IMUX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2014
- SEC CIK: 0001280776
- Website: immunic-therapeutics.com

## About

Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.

## Latest IMUX news and filings

- 2026-11-05 14:00 UTC [SEC Form 8-K] [Immunic Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/immunic-inc-filed-sec-form-8-k-regulation-fd-disclosure-financial-6775161)
- 2026-11-02 13:47 UTC [SEC Schedule 13G] [Amendment: SEC Form SCHEDULE 13G/A filed by Immunic Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-immunic-inc-6766392)
- 2026-11-02 11:30 UTC [Conference Announcement] [Immunic to Participate in Investor Conferences in November](https://www.quantisnow.com/insight/immunic-to-participate-in-investor-conferences-in-november-6765948)
- 2026-10-29 10:30 UTC [Immunic to Host Virtual Progressive Multiple Sclerosis R&D Day on November 5, 2026](https://www.quantisnow.com/insight/immunic-to-host-virtual-progressive-multiple-sclerosis-rd-day-on-6762194)
- 2026-10-23 11:35 UTC [Analyst Coverage Initiated] [Cantor Fitzgerald initiated coverage on Immunic](https://www.quantisnow.com/insight/cantor-fitzgerald-initiated-coverage-on-immunic-6755834)
- 2026-10-21 11:00 UTC [Immunic Presents New Clinical, Biomarker, and Preclinical Data for Vidofludimus Calcium in Four Poster Presentations at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting](https://www.quantisnow.com/insight/immunic-presents-new-clinical-biomarker-and-preclinical-data-for-vidofludimus-6752827)
- 2026-10-19 10:30 UTC [Leadership Update] [Immunic Appoints Jaa Roberson as Chief People Officer](https://www.quantisnow.com/insight/immunic-appoints-jaa-roberson-as-chief-people-officer-6750027)
- 2026-10-07 12:00 UTC [Immunic to Present New Clinical, Biomarker and Preclinical Data on Vidofludimus Calcium at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting](https://www.quantisnow.com/insight/immunic-to-present-new-clinical-biomarker-and-preclinical-data-on-6739746)
- 2026-10-01 20:05 UTC [SEC Form S-8] [SEC Form S-8 filed by Immunic Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-immunic-inc-6732375)
- 2026-09-19 01:00 UTC [SEC Form 4] [SEC Form 4 filed by Director Nagel Robert Thorvald](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-nagel-robert-thorvald-6721016)
- 2026-09-18 23:45 UTC [SEC Form 4] [SEC Form 4 filed by See Explanation of Responses Bvf Partners L P/Il](https://www.quantisnow.com/insight/sec-form-4-filed-by-see-explanation-of-responses-bvf-6720983)
- 2026-09-11 21:24 UTC [SEC Form 8-K] [Immunic Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/immunic-inc-filed-sec-form-8-k-leadership-update-financial-statements-6713320)
- 2026-09-09 13:01 UTC [SEC Form 8-K] [Immunic Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/immunic-inc-filed-sec-form-8-k-regulation-fd-disclosure-financial-6709587)
- 2026-09-02 10:30 UTC [Conference Announcement] [Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026](https://www.quantisnow.com/insight/immunic-to-host-virtual-relapsing-multiple-sclerosis-rd-day-on-6702208)
- 2026-09-01 10:30 UTC [Leadership Update] [Immunic Appoints Chitrang Davé as Chief Data and Digital Officer](https://www.quantisnow.com/insight/immunic-appoints-chitrang-dav-as-chief-data-and-digital-officer-6700403)
- 2026-08-17 12:23 UTC [Analyst Coverage Initiated] [Wedbush initiated coverage on Immunic with a new price target](https://www.quantisnow.com/insight/wedbush-initiated-coverage-on-immunic-with-a-new-price-target-6684400)
- 2026-08-14 21:31 UTC [SEC Form SCHEDULE 13G filed by Immunic Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-immunic-inc-6683790)
- 2026-08-12 20:05 UTC [SEC Form S-8] [SEC Form S-8 filed by Immunic Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-immunic-inc-6677815)
- 2026-08-11 11:05 UTC [SEC Form 8-K] [Immunic Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/immunic-inc-filed-sec-form-8-k-results-of-operations-and-6674892)
- 2026-08-11 10:59 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Immunic Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-immunic-inc-6674814)
- 2026-08-11 10:30 UTC [Leadership Update] [Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update](https://www.quantisnow.com/insight/immunic-inc-reports-second-quarter-2026-financial-results-and-provides-6674776)
- 2026-08-10 23:00 UTC [SEC Form 4] [SEC Form 4 filed by Director Ridloff Elena](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-ridloff-elena-6674510)
- 2026-08-10 22:59 UTC [SEC Form 3] [SEC Form 3 filed by new insider Ridloff Elena](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-ridloff-elena-6674508)
- 2026-08-10 20:05 UTC [Leadership Update] [Immunic Appoints Elena Ridloff to Board of Directors](https://www.quantisnow.com/insight/immunic-appoints-elena-ridloff-to-board-of-directors-6673568)
- 2026-07-14 12:01 UTC [SEC Form 8-K] [Immunic Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/immunic-inc-filed-sec-form-8-k-regulation-fd-disclosure-financial-6636125)
- 2026-07-09 10:30 UTC [Conference Announcement] [Immunic to Participate in Investor Conferences in July](https://www.quantisnow.com/insight/immunic-to-participate-in-investor-conferences-in-july-6632291)
- 2026-07-07 20:07 UTC [SEC Form 4] [SEC Form 4 filed by Director Skerjanec Simona](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-skerjanec-simona-6630049)
- 2026-07-07 20:06 UTC [SEC Form 4] [SEC Form 4 filed by Director Rudick Richard Alan](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-rudick-richard-alan-6630044)
- 2026-07-07 20:06 UTC [SEC Form 4] [SEC Form 4 filed by Director Phillips Barclay A](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-phillips-barclay-a-6630039)
- 2026-07-07 20:05 UTC [SEC Form 4] [SEC Form 4 filed by Director Neermann Joerg](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-neermann-joerg-6630029)
- 2026-07-07 20:05 UTC [SEC Form 4] [SEC Form 4 filed by Director Congleton Jon](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-congleton-jon-6630014)
- 2026-07-06 20:22 UTC [SEC Form 8-K] [Immunic Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/immunic-inc-filed-sec-form-8-k-leadership-update-6628317)
- 2026-06-29 20:34 UTC [SEC Form 4] [SEC Form 4 filed by Director Congleton Jon](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-congleton-jon-6619193)
- 2026-06-29 20:34 UTC [SEC Form 4] [SEC Form 4 filed by Director Skerjanec Simona](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-skerjanec-simona-6619185)
- 2026-06-29 20:33 UTC [SEC Form 4] [SEC Form 4 filed by Director Rudick Richard Alan](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-rudick-richard-alan-6619181)
- 2026-06-29 20:33 UTC [SEC Form 4] [SEC Form 4 filed by Director Howson Tamar D](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-howson-tamar-d-6619178)
- 2026-06-29 20:31 UTC [SEC Form 4] [SEC Form 4 filed by Chief Financial Officer Whaley Glenn](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-financial-officer-whaley-glenn-6619176)
- 2026-06-29 20:31 UTC [SEC Form 4] [SEC Form 4 filed by President and COO Tardio Jason](https://www.quantisnow.com/insight/sec-form-4-filed-by-president-and-coo-tardio-jason-6619169)
- 2026-06-29 20:32 UTC [SEC Form 4] [SEC Form 4 filed by Director Neermann Joerg](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-neermann-joerg-6619164)
- 2026-06-29 20:32 UTC [SEC Form 4] [SEC Form 4 filed by Director Phillips Barclay A](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-phillips-barclay-a-6619163)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/IMUX
- Earnings history: https://www.quantisnow.com/earnings/IMUX
- Dividend history: https://www.quantisnow.com/dividends/IMUX
- Insider transactions: https://www.quantisnow.com/insiders/IMUX
- Options chain: https://www.quantisnow.com/options/IMUX
- SEC 8-K filings only: https://www.quantisnow.com/company/IMUX/8-k
- RSS and alerts for IMUX: https://www.quantisnow.com/docs/rss-feeds.md